Search This Blog

Friday, April 08, 2016

Prior studies documenting the costs of care for patients with ovarian cancer have either used a brief period of time, or have
described costs for a particular treatment type.6–8
Our objectives were to use the SEER-Medicare data set to describe the
costs of care for patients with ovarian cancer in the
first year after diagnosis, evaluate differences in
costs depending on treatment approach, and evaluate factors responsible
for variation.

Conclusions: The financial burden of caring for
patients with ovarian cancer is substantial. Treatment that is
consistent with NCCN recommendations
for treating advanced ovarian cancer, which is
shown to have improved outcomes, is not associated with higher cost.